|
 |
| hn |
|
Horwitz, E., Harris, J., Langer, C., Nicolaou, N., Kies, M., Curran Jr, W., Wong, S. and Ang, K. K.: Concurrent Split Course Hyperfractionated Radiotherapy (Hfx RT), Cisplatin (DDP) and Paclitaxel (P) in Patients with Recurrent, Previously Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN): Update of RTOG 9911. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 519s, Abs. #5577, 2005. |
9911 |
chemo |
 |
| hn |
|
Ridge, J., Harris, J., Peters, G., Jones, C., Har-El, G., Singer, M., Black, M., Cooper, J., Ang, K. K. and Weber, R.: Early Neck Dissection After Radiation Therapy Improves Regional Control And Survival With Head And Neck Cancer: RTOG Trial 90-03. Am Head & Neck Society (AHNS), Boca Raton, FL, AHNS Annual Meeting Program, pg. 68-69, Abs. #146, 2005. |
9003 |
rt/fractionation |
|
| hn |
|
Trotti, A., Pajak, T., Gwede, C., Cooper, J. and Ang, K. K.: Are We Systematically Under-reporting Toxicity? An Evaluation of the RTOG "Worst Grade Summary Method" for Reporting Clinical Trial Adverse Event Data. Amer Radium Society (ARS), Barcelona, Spain, ARS Meeting Booklet, pg. Abs. #123, 2005. |
9003
9111
9501
9703
9914 |
surg |
|
| hn |
|
Trotti, A., Pajak, T., Gwede, C., Paulus, R., Cooper, J., Forastiere, A., Garden, A. and Ang, K. K.: The TAME Adverse Event Summary and Risk Classification System:Analysis of the RTOG H&N Database. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 534s, Abs. #6026, 2005. |
9003
9111
9501
9703
9914 |
surg |
|
| hn |
|
Kumar, P., Robbins, K. T., Harris, J., McCulloch, T., Cmelak, A., Sofferman, R., Levine, P. and Fu, K.: Mature Results of Radiation Therapy Oncology Group (RTOG) Trial 9615 Using Intra-Arterial Cisplatin (IA-P) and Concurrent Radiation Therapy (RT) for Stage IV-T4 Head/Neck (H/N) Squamous Cell Carcinoma (SCCa). Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 519s, Abs. #5579, 2005. |
9615 |
chemo |
|
| hn |
|
Pajak, T., Trotti, A., Gwede, C., Paulus, R., Cooper, J., Ridge, J. A., Fu, K. and Ang, K. K.: The TAME Risk Classification System: Acute Toxicity Burden and IPD Analysis of RTOG 90-03. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S131, Abs. #217, 2005. |
9003 |
surg |
|
| hn |
|
Horwitz, E., Harris, J., Langer, C., Nicolaou, N., Kies, M., Curran Jr, W., Wong, S. and Ang, K. K.: Phase II Study of Paclitaxel and Cisplatin in Combination with Split Course Concomitant Hyperfractionated Re-Irradiation in Patients with Recurrent Squamous Cell Cancer of the Head and Neck: Results of RTOG 99-11. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S72-S73, Abs. #119, 2005. |
9911 |
chemo |
|
| hn |
|
Garden, A., Harris, J., Jones, C., Trotti, A., Carrascosa, L., Cheng, J., Spencer, S., Weber, R. and Ang, K. K.: Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Update of a Phase II Trial of the RTOG (99-14). Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S71-S72, Abs. #117, 2005. |
9914 |
chemo/lateff |
|
| hn |
|
Trotti, A., Fu, K., Pajak, T., Jones, C. U., Spencer, S. A., Phillips, T. L., Garden, A. S., Ridge, J. A., Cooper, J. S. and Ang, K.: Long Term Outcomes of RTOG 90-03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S70-S71, Abs. #116, 2005. |
9003 |
surg |
|
| hn |
|
Foote, R., Weidner, N., Harris, J., Hammond, E., Lewis, J. E., Vuong, T., Ang, K. K. and Fu, K.: Evaluation of Tumor Angiogenesis Measured with Microvessel Density (MVD) as a Prognostic Indicator in Nasopharyngeal Carcinoma: Results of RTOG 9505. Int J Radiat Onco Biol Phys, 2005. |
9505 |
MVD/path |
|
| hn |
|
Ang, K. K., Harris, J., Garden, A., Trotti, A., Jones, C., Carrascosa, L., Cheng, J., Spencer, S., Forastiere, A. and Weber, R.: Concomitant Boost Radiation plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14). J Clin Oncol, 2005. |
9914 |
chemo |
|
| hn |
|
Robbins, K. T., Kumar, P., Harris, J., McCulloch, T., Cmelak, A., Sofferman, R., Levine, P., Weisman, R., Wilson, W., Weymuller Jr., E. and Fu, K.: Supradose Intra-Arterial Cisplatin and Concurrent Radiation Therapy for the Treatment of Stage IV Head and Neck Squamous Cell Carcinoma Is Feasible and Efficacious in a Multi-Institutional Setting: Results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol, 23 (7):1447-1454, 2005. |
9615 |
chemo |
|
| hn |
|
Mukherji, S. K., Toledano, A. Y., Beldon, C., Schmalfuss, I. M., Cooper, J., Sicks, J., Amdur, R., Sailer, S., Loevner, L., Kousouboris, P. and Ang, K. K.: Interobserver Reliability of Computed Tomography-Derived Primary Tumor Volume Measurement in Patients with Supraglottic Carcinoma. Cancer, 103 (12):2616-2622, 2005. |
9111/ACRIN 6658 |
radio |
|
| hn |
|
Bernier, J., Cooper, J., Pajak, T., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozahin, E., Jacobs, J., Jassem, J., Ang, K. K. and Lefebvre, J.: Defining Risk Levels in Locally Advanced Head and Neck Cancers: A Comparative Analysis of Concurrent Postoperative Radiation Plus Chemotherapy Trials of the EORTC (#22931) and RTOG (# 9501). Head & Neck Surg, October (27):843-850, 2005. |
9501 |
chemo |
|
| hn |
|
Ang, K. K.: Concurrent Radiation Chemotherapy for Locally Advanced Head and Neck Carcinoma: Are We Addressing Burning Subjects? J Clin Oncol, 1-3, 2004. |
|
EGFR
chemo |
|
| hn |
|
Cooper, J. and Ang, K. K.: Concomitant Chemotherapy and Radiation Therapy Certainly Improves Local Control. Int J Radiat Onco Biol Phys, 7-9, 2005. |
|
chemo/rt |
|
| hn |
|
Garden, A. S., Harris, J., Vokes, E., Forastiere, A., Ridge, J., Jones, C., Horwitz, E., Glisson, B., Nabell, L., Cooper, J., Demas, W. and Gore, E.: Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck. J Clin Oncol, 22 (14):2856-2864, 2004. |
9703 |
chemo |
|
| hn |
9003, 9111 |
Pajak, T., Konski, A., Movsas, B., Coyne, J., Harris, J., Gwede, C., Garden, A., Spencer, S., Jones, C. and Watkins Bruner, D.: Marital Status and Gender Interaction Affecting Survival in RTOG Head and Neck Trials. 6th Int'l Conference on Head and Neck Cancer, Washington, DC, AHNS 6th Abstract Program Book, pg. 240, Abs. #s114, 2004. |
9003, 9111, 9703 |
Outcomes/socio-demographic/chemo |
|
| hn |
9501 |
Bernier, J., Cooper, J., van Glabbeke, M., Pajak, T., Bourhis, J., Forastiere, A., Ozsahin, M., Jacobs, J., Matuszewska, K., Fu, K., Lefebvre, J. and Ang, K. K.: Chemo-Radiation as Adjuvant Treatment in Locally Advanced Head & Neck Squamous Cell Carcinomas (HNSCC): Comparative Analysis of Selection Criteria, Disease Patterns and Treatment Outcomes in EORTC 22931 and RTOG 9501/Intergroup Trials. 6th Int'l Conference on Head and Neck Cancer, Washington, DC, AHNS 6th Abstract Program Book, pg. 292, Abs. #s324, 2004. |
9501 |
chemo |
|
| hn |
|
Horwitz, E., Harris, J., Langer, C., Nicolaou, N., Kies, M., Curran Jr, W., Wong, S. and Ang, K. K.: RTOG 9911: Phase II Study of Concurrent Chemotherapy and Re-Irradiation for Recurrent Head & Neck Cancer. 6th Int'l Conference on Head and Neck Cancer, Washington, DC, AHNS 6th Abstract Program Book, pg. 249, Abs. #s151, 2004. |
9911 |
chemo |
|
| hn |
|
Spencer, S., Harris, J., Wheeler, R., Machtay, M., Schultz, C., Spanos, W., Rotman, M., Meredith, R. and Ang, K. K.: Late Effects After Re-irradiation And Chemotherapy In Patients With Squamous Cell Cancer Of The Head And Neck: RTOG 96-10. 6th Int'l Conference on Head and Neck Cancer, Washington, DC, AHNS 6th Abstract Program Book, pg. 234, Abs. #s089, 2004. |
9610 |
chemo |
|
| hn |
9003, 9111 |
Movsas, B., Konski, A., Harris, J., Coyne, J., Gwede, C., Garden, A., Spencer, S., Jones, C. and Watkins Bruner, D.: Quality of Life (QOL) Variables Influence Survival in Radiation Therapy Oncology Group (RTOG) Head & Neck Trials. Int Soc QOL Res (ISOQOL), Boston, MA, Quality of Life Research, [June 27-29, 2004] pg. 53, Abs. #122, 2004. |
9003, 9111 |
Outcomes/QOL |
|
| hn |
|
Koch, W., Benoit, N., Poeta, L., Goldenberg, D., Califano, J., Ridge, J., Goodwin, J., Kenady, D., Forastiere, A. and Sidransky, D.: Spectrum of Mutation of p53 in HNSCC: Results of Intragroup Margin Study. 6th Int'l Conference on Head and Neck Cancer, Washington, DC, AHNS 6th Abstract Program Book, pg. 242, Abs. #s124, 2004. |
9614 |
p53
surg |
|
| hn |
9003 |
Machtay, M., Pajak, T., Suntharalingam, M., Hershock, D., Stripp, D. C., Cmelak, A., Shenouda, G., Schulsinger, A. and Fu, K.: Definitive Radiotherapy +/- Erythropoietin for Squamous Cell Carcinoma of the Head and Neck: Preliminary Report of RTOG 99-03. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S132, Abs. #5, 2004. |
9903 |
chemo |
|
| hn |
|
Rosenthal, D., Harris, J., Forastiere, A., Weber, R., Ridge, J., Myers, J., Garden, A., Kuettel, M., Sidhu, K., Schultz, C. and Ang, K. K.: Early Postoperative Paclitaxel Followed by Paclitaxel and Cisplatin Concurrent with Radiation Therapy (RT) (Phase II Trial RTOG H-0024) is Well Tolerated for Patients with Resected, High-Risk Squamous Carcinoma of the Head and Neck (HNSCC). Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S322, Abs. #1111, 2004. |
0024 |
chemo |
|
| hn |
9003, 9111 |
Movsas, B., Konski, A., Pajak, T., Coyne, J., Gwede, C., Garden, A., Spencer, S., Jones, C. and Watkins Bruner, D.: Quality of Life (QOL) Variables Influence Local Regional Control in Radiation Therapy Oncology Group (RTOG) Head & Neck Trials (9003 and 9111). Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S252, Abs. #199, 2004. |
9003, 9111 |
Outcomes/QOL |
|
| hn |
9003 |
Kumar, P., Harris, J., Garden, A., Fu, K., Robbins, K. T., Pajak, T. and Ang, K. K.: Comparison of Intra-Arterial Cisplatin and Radiation Therapy to Other Radiation Therapy Oncology Group (RTOG) Regimens Using Standard or Accelerated RT with or without Concurrent Chemotherapy in Patients with Stage IV-T4 Head and Neck Cancer. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S495-496, Abs. #2266, 2004. |
8117, 9003, 9615, 9703 |
chemo |
|
| hn |
|
Ang, K. K., Andratschke, N. H. and Milas, L.: Epidermal Growth Factor Receptor and Response of Head-and-Neck Carcinoma to Therapy. Int J Radiat Onco Biol Phys, 58 (3):959-965, 2004. |
EGFR |
chemo/rt |
|
| hn/larynx |
9111 |
Bourhis, J., Amand, C. and Pignon, J.-P.: Update of MACH-NC (Meta-Analysis of CT in Head & Neck Cancer) Database Focused on Concomitant Chemoradiotherapy. 6th Int'l Conference on Head and Neck Cancer, Washington, DC, AHNS 6th Abstract Program Book, pg. 212, Abs. #s003, 2004. |
9111 |
chemo |
|
| hn |
9501 |
Cooper, J., Pajak, T., Forastiere, A., Jacobs, J., Campbell, B., Saxman, S., Kish, J., Kim, H., Cmelak, A., Rotman, M., Machtay, M., Ensley, J., Chao, C., Schultz, C., Lee, N. and Fu, K.: Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck. New Eng J Med, 350 (19):1937-1944, 2004. |
9501 |
surg/chemo/rt |
|
| hn |
|
Langer, C., Harris, J., Horwitz, E., Nicolaou, N., Kies, M., Curran Jr, W., Wong, S. and Ang, K. K.: Phase II Trial Of Concurrent Split Course Hyperfractionated Radiotherapy (Hfx RT), Cisplatin (DDP) and Paclitaxel (P) in Patients with Recurrent, Previously Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN): Results of RTOG 9911. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 488, Abs. #5509, 2004. |
9911 |
chemo |
|
| hn |
9003, 9111 |
Konski, A., Pajak, T., Movsas, B., Coyne, J., Harris, J., Gwede, C., Garden, A., Spencer, S., Jones, C. and Watkins Bruner, D.: Socio-Demographic Variables Influence Outcome in Radiation Therapy Oncology Group Head and Neck Trials. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 527, Abs. #6043, 2004. |
9003, 9111, 9703 |
socio-demographic |
|
| hn |
9003, 9111 |
Coyne, J., Pajak, T., Harris, J., Konski, A., Movsas, B., Ang, K. K. and Bruner, D.: Depressed Mood and Survival Among Patients with Head and Neck Cancer. Am Psychosomatic Soc, Orlando, FL, Proceedings from Am Psychosomatic Bklt, [March, 2004] pg. 11, Abs. #1566, 2004. |
9003, 9111, 9703 |
QOL |
|
| hn |
9003 |
Kumar, P., Harris, J., Garden, A., Fu, K., Robbins, K. T., Pajak, T. and Ang, K. K.: Outcome Comparisons of Four Radiation Therapy Oncology Group (RTOG) Trials in Patients with Stage IV-T4 Head and Neck (H/N) Cancer: Encouraging Results Using Intra-Arterial (IA) Cisplatin (P) and Radiation Therapy (RT). Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 493, Abs. #5527, 2004. |
8117, 9003, 9615, 9703 |
chemo |
|
| hn |
|
Trotti, A., Garden, A., Warde, P., Symonds, P., Langer, C., Redman, R., Pajak, T., Fleming, T., Henke, M., Bourhis, J., Rosenthal, D., Junor, E., Cmelak, A., Sheehan, F., Pulliam, J., Risse, P., Fuchs, H., Chambers, M., O'Sullivan, B. and Ang, K. K.: A Multinational, Randomized Phase III Trial of Iseganan HCL Oral Solution for Reducing the Severity of Oral Mucositis in Patients Receiving Radiotherapy for Head-and-Neck Malignancy. Int J Radiat Onco Biol Phys, 58 (3):674-681, 2004. |
|
cacon |
|
| hn |
|
Ang, K. K., Andratschke, N. H. and Milas, L.: Epidermal Growth Factor Receptor and Response of Head-and-Neck Carcinoma to Therapy. Int J Radiat Onco Biol Phys, 58 (3):959-965, 2004. |
EGFR |
chemo/rt |
|
| hn |
9003, 9111 |
Trotti, A., Gwede, C., Pajak, T., Paulus, R. and Saranga, S.: The TAME Summary Reporting and Risk Classification System for Comparing Treatment Options in Oncology. LENT V Workshop, Rochester, NY, LENT V Meeting Booklet, pg. Session 4, Abs. #1, 2004. |
9003, 9111 |
biomarkers |
|
| hn |
9501 |
Bernier, J., Domenge, C., Ozsahin, M., Matuszewska, K., Lefebvre, J., Greiner, R., Giralt, J., Maingon, P., Rolland, F., Bolla, M., Cognetti, F., Bourhis, J., Kirkpatrick, A. and van Glabbeke, M.: Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer. New Eng J Med, 350 (19):1945-1952, 2004. |
9501 |
surg/chemo/rt |
|
| hn/larynx |
9111 |
Bourhis, J., Amand, C. and Pignon, J.-P.: Update of MACH-NC (Meta-Analysis of Chemotherapy In Head & Neck Cancer ) Database Focused on Concomitant Chemotherapy. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 488, Abs. #5505, 2004. |
9111 |
chemo |
|
| hn |
|
Spencer, S., Harris, J., Wheeler, R., Machtay, M., Schultz, C., Spanos, W., Rotman, M., Meredith, R. and Ang, K. K.: Late Effects of RTOG-9610: Re-Irradiation and Chemotherapy in Patients with Squamous Cell Cancer of The Head and Neck. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S307, Abs. #1077, 2003. |
9610 |
hn
chemo |
|
| hn |
9003 |
Tu, X., Berkey, B., Zhang, H., Hammond, E., Cooper, J., Spencer, S., Trotti, A., Fu, K., Milas, L. and Ang, K. K.: Impact of EGFR Expression on the Response of Advanced Head and Neck Carcinomas to Concomitant Boost Radiotherapy in a RTOG Phase III Trial (90-03). Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S157, Abs. #56, 2003. |
9003 |
hn
EGFR
path |
|
| hn |
9111 |
Weber, R., Berkey, B., Forastiere, A., Cooper, J., Maor, M., Goepfert, H., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D., Leaf, A. and Ensley, J.: Outcome of Salvage Total Laryngectomy Following Organ Preservation Therapy: The Radiation Therapy Oncology Group Trial 91-11. Arch Otolary H&N Surg, 129 (Jan 2003):44-49, 2003. |
9111 |
hn/larynx
surg |
|
| hn |
9003 |
Konski, A., Berkey, B., Ang, K. K. and Fu, K.: Effect of Education Level on Outcome of Patients Treated on Radiation Therapy Oncology Group Protocol 90-03. Cancer, 98 (7):1497-1503, 2003. |
9003 |
hn
ECON |
|
| hn |
9003 |
Hammond, E., Berkey, B., Fu, K., Trotti, A., Meredith, R., Jones, C., Byhardt, R., Horwitz, E. and Ang, K. K.: p105 as a Prognostic Indicator in Patients Irradiated for Locally Advanced Head-and-Neck Cancer: A Clinical/Laboratory Correlative Analysis of RTOG 90-03. Int J Radiat Onco Biol Phys, 57 (3):683-692, 2003. |
9003 |
hn
marker/p105
surg |
|
| hn |
9111 |
Forastiere, A., Goepfert, H., Maor, M., Pajak, T., Weber, R., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D.-J., Leaf, A., Ensley, J. and Cooper, J.: Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer. New Eng J Med, 349 (22):2091-2098, 2003. |
9111 |
hn/larynx
medonc |
|
| hn |
9709 |
Fisher, J., Scott, C., Scarantino, C., Leveque, F. G., White, R., Rotman, M., Hodson, D., Meredith, R., Foote, R., Brachman, D. and Lee, N.: Phase III Quality-of-Life Study Results: Impact on Patients' Quality of Life to Reducing Xerostomia after Radiotherapy for Head-and-Neck Cancer—RTOG 97-09. Int J Radiat Onco Biol Phys, 56 (3):832-836, 2003. |
9709 |
hn
QOL |
|
| hn |
|
Khuri, F., Lee, J. J., Lippman, S. M., Kim, E. S., Cooper, J., Benner, S., Vokes, E., Pajak, T., Goepfert, H. and Hong, W. K.: Isotretinoin Effects on Head and Neck Cancer Recurrence and Second Primary Tumors. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 90, Abs. #359, 2003. |
9115 |
hn
chemo |
|
| hn |
9111 |
Maor, M., Berkey, B., Forastiere, A., Weber, R., Goepfert, H., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D., Leaf, A., Ensley, J. and Fu, K.: Larynx Preservation and Tumor Control in Stage III and IV Laryngeal Cancer: A Three-Arm Randomized Intergroup Trial; RTOG 91–11. Proc Am Soc Clin Oncol (ASCO)-Best of Oncology Session, Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. Abs. #Selected, 2003. |
9111 |
hn/larynx
surg |
|
| hn |
9003 |
Ang, K. K., Berkey, B., Tu, X., Zhang, H., Katz, R., Hammond, E., Fu, K. and Milas, L.: Impact of Epidermal Growth Factor Receptor Expression on Survival and Pattern of Relapse in Patients with Advanced Head and Neck Carcinoma. Cancer Research, 62 7350-7356, 2002. |
9003 |
EGFR path |
|
| hn/larynx |
9111 |
Weber, R., Berkey, B., Forastiere, A., Cooper, J., Maor, M., Goepfert, H., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D., Leaf, A. and Ensley, J.: Outcome of Salvage Total Laryngectomy Following Organ Preservation Therapy: The Radiation Therapy Oncology Group Trial 91-11. Arch Otolary H&N Surg, 129 (Jan 2003):44-49, 2003. |
9111 |
surg |
|
| hn |
9003 |
Eldridge, B., Rabinovitch, R., Berkey, B., Rahen, D., Ang, K. K. and Fu, K.: The Impact Of Baseline Nutritional Support On Treatment Outcome In Patients With Locally Advanced Squamous Cell Cancer Of The Head And Neck Treated With Definitive Radiotherapy: Report Of The Radiation Therapy Oncology Group (RTOG) Trial 90-03. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 115, Abs. #194, 2002. |
9003 |
other |
|
| hn |
9003 |
Ang, K. K., Berkey, B., Tu, X., Zhang, H., Hammond, E., Fu, K. and Milas, L.: Impact of Epidermal Growth Factor Receptor Expression on Survival and Pattern of Relapse in Patients with Advanced Head and Neck Carcinoma. NCI-EORTC Meeting, Washington, DC, Int'l J Bio Markers, [17] (S2) pg. S16-S17, Abs. 2002. |
9003 |
EGFR path |
|
| hn |
9607 |
Johnson, D., Scott, C., Marks, J., Seay, T., Atkins, J., Berk, L., Meoz, R. and Wheeler, J.: Assessment of Quality of Life and Oral Function of Patients Participating in a Phase II Study of Radioprotection of Oral and Pharyngeal Mucosa by the Prostaglandin E1 Analog Misoprostol (RTOG 96-07). Int J Radiat Onco Biol Phys, 54 (5):1455-1459, 2002. |
9607 |
QOL |
|
| hn |
9501 |
Cooper, J., Pajak, T., Forastiere, A., Jacobs, J., Saxman, B., Kish, J., Kim, H., Cmelak, A., Rotman, M., Machtay, M., Ensley, J., Chao, C., Schultz, C., Lee, N. and Fu, K.: Patterns of Failure for Resected Advanced Head & Neck Cancer Treated By Concurrent Chemotherapy and Radiation Therapy: An Analysis of RTOG 95-01/Intergroup Phase III Trial. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 2, Abs. #3, P., 2002. |
9501 |
surg/chemo/rt |
|
| hn |
9914 |
Ang, K. K., Harris, J., Garden, A., Jones, C., Trotti, A., Cheng, J., Spencer, S. and Weber, R.: Concomitant Boost Radiation And Concurrent Cisplatin For Advanced Head And Neck Carcinomas: Preliminary Results Of A Phase II Trial Of The RTOG (99-14). Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 71, Abs. #118, 2002. |
9914 |
chemo/rt |
|
| hn |
9111 |
Maor, M., Berkey, B., Forastiere, A., Weber, R., Goepfert, H., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D., Leaf, A., Ensley, J. and Fu, K.: Larynx preservation and tumor control in stage III and IV laryngeal cancer: a three-arm randomized intergroup trial; RTOG 91–11. Proc Am Soc Thera Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, [54] (2) pg. 2-3, Abs. #4, P., 2002. |
9111 |
surg |
|
| hn |
|
Chao, C.: Protection of Salivary Function by Intensity-Modulated Radiation Therapy in Patients with Head and Neck Cancer. Sem in Rad Oncol, 12 (1 (Suppl 1):20-25, 2002. |
|
lateff |
|
| hn |
9501 |
Cooper, J., Pajak, T., Forastiere, A., Jacobs, J., Saxman, B., Kish, J., Kim, H., Cmelak, A., Rotman, M., Machtay, M., Ensley, J., Chao, C., Schultz, C., Lee, N. and Fu, K.: Postoperative Concurrent Radiochemotherapy In High-Risk SCCA of The Head And Neck: Initial Report Of RTOG 95-01/Intergroup Phase III Trial. Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 226a, Abs. #903, 2002. |
9501 |
surg/chemo/rt |
|
| hn |
9505 |
Hammond, E., Weidner, N., Harris, J., Fu, K., Foote, R., Hammond, J., Vuong, T., Sagar, S. and Ang, K. K.: Prognostic Value of Intratumoral Microvessel Density in Nasopharyngeal Carcinoma: Results of RTOG Study 95-05. US/Canadian Pathology, Chicago, IL, J US & Canadian Acad Path, pg. 140, Abs. #919, 2002. |
9505 |
marker/MVD path |
|
| hn |
9111 |
Weber, R., Berkey, B., Forastiere, A., Maor, M., Goepfert, H., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D., Leaf, A. and Ensley, J.: Outcome for Salvage Total Laryngectomy (TL) Following Organ Preservation Therapy: The Radiation Therapy Oncology Group Trial 91-11. Amer H & N Society Mtg (AHNS), Boca Raton, FL, Am H&N Soc (COSM) Booklet, pg. Abs. #168, 2002. |
9111 |
surg |
|
| hn |
9709 |
Fisher, J., Scott, C., Scarantino, C., Leveque, F. G., White, R., Rotman, M., Hodson, D., Meredith, R., Foote, R., Brachman, D. and Lee, N.: Phase III Quality Of Life (QOL) Study: Reduction In Hyposalivation Does Not Improve QOL For Head And Neck (H&N) Cancer Patients Post Radiation Therapy (P-RT). RTOG 9709. Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 356a, Abs. #1423, 2002. |
9709 |
QOL |
|
| hn |
9003 |
Konski, A., Berkey, B., Ang, K. K. and Fu, K.: The Effect Of Education Level On Outcome Of Patients Treated On Radiation Therapy Oncology Group (RTOG) Protocol 90-03. Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 249a, Abs. #992, 2002. |
9003 |
ECON |
|
| hn |
|
Lee, J., Kim, E., Khuri, F., Feng, L., Chamberlain, R. M., Williams, B., Fu, K., Cooper, J., Ang, K. K., Lippman, S. M., Goepfert, H. and Hong, W. K.: Longterm Adherence in a Head and Neck Chemoprevention Trial. Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, Am Soc Clin Oncol, 21: pg. 236a, Abs. #940, 2002. |
9115 |
chemo |
|
| hn |
|
Trotti, A., Garden, A., Warde, P., Symonds, P., Langer, C., Fleming, T., Redman, R., Henke, M., Bourhis, J. and Ang, K. K.: Phase III Trial of Iseganan HCI Oral Solution (Iseganan) for Reducing Oral Mucositis Severity in Patients Receiving Radiotherapy for Head and Neck Malignancies (PROMPT-RT). Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 228a, Abs. #908, 2002. |
|
cacon |
|
| hn |
9003 |
Calvin, D., Hammond, E., Pajak, T., Trotti, A., Meredith, R., Rotman, M., Jones, C., Byhardt, R., Demas, W., Ang, K. K. and Fu, K.: Microvessel Density (MVD) > 60 Does Not Predict for Outcome in Advanced Head And Neck Squamous Cell Carcinoma (HNSCC): Results of A Prospective Study From the RTOG 90-03 Trial. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 41, Abs. #68, 2001. |
9003 |
path |
|
| hn |
9003 |
Fisher, J., Scott, C., Fu, K., Trotti, A., Spencer, S., Garden, A., Phillips , T., Movsas, B., Byhardt, R. and Ang, K. K.: Treatment, Patient and Tumor Characteristics Impact Quality of Life (QOL) In Patients With Locally Advanced Head and Neck Cancer: Report of The Radiation Therapy Oncology Group (RTOG) Trial 90-03. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 98, Abs. #174, 2001. |
9003 |
QOL |
|
| hn |
9607 |
Johnson, D., Scott, C., Marks, J., Seay, T., Atkins, J., Berk, L., Meoz, R. and Wheeler, J.: Assessment of Quality of Life And Oral Function of Patients Participating In A Phase II Study of Radioprotection of Oral And Pharyngeal Mucosa by the Prostaglandin E1 Analoge Misoprostol (RTOG 96-07). Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 97-98, Abs. #173, 2001. |
9607 |
QOL |
|
| hn |
9003 |
Konski, A., Scott, C., Ang, K. and Fu, K.: Cost-Utility Analysis of RTOG 90-03: Phase III Randomized Study Comparing Altered Fractionation To Standard Fractionation Radiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 48, Abs. #82, 2001. |
9003 |
ECON |
|
| hn |
9709 |
Scarantino, C., Leveque, F. G., Scott, C., White, R., Rotman, M., Hodson, D., Meredith, R., Foote, R., Brachman, D. and Lee, N.: A Phase III Study on the Concurrent Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated with Radiation Therapy In Head And Neck Cancer Patients. Final Results of RTOG 97-09. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 85-86, Abs. #152, 2001. |
9709 |
cacon |
|
| hn |
|
Spencer, S., Harris, J., Wheeler, R., Machtay, M., Shultz, C., Spanos, W., Rotman, M. and Meredith, R.: RTOG 96-10: Reirradiation with Concurrent Hydroxyurea and 5-Fluorouracil in Patients with Squamous Cell Cancer of the Head and Neck. Int J Radiat Onco Biol Phys, 51(5):1299-1304, 2001. |
9610 |
chemo |
|
| hn |
|
Cooper, J., Berkey, B., Marcial, V., Lee, D. and Fu, K. K.: Validation of the RTOG Recursive Partitioning Classification for Head and Neck Tumors. Head and Neck Journal, 23(8):669-677, 2001. |
8527 |
stat |
|
| hn |
9003 |
Owen, J., Grigsby, P., Caldwell, T., Konski, A., Johnson, D., Demas, W., Movsas, B., Jones, C. V. and Wasserman, T.: Can Costs Be Measured And Predicted by Modeling Within A Cooperative Clinical Trials Group? Economic Methodological Pilot Studies of Radiation Therapy Oncology Group (RTOG) Studies 90-03 and 91-04. Int J Radiat Oncol Biol Phys, 49(3):633-639, 2001. |
9003, 9104 |
ECON |
|
| hn |
|
Milanes-Yearsley, M., Hammond, E. and Pajak, T.: Tissue Micro Arrays in Immuno-Histochemistry: A Practical, Cost-Effective and Time-Effective Research Tool. US/Canadian Pathology, Atlanta, GA, J US & Canadian Acad Path, #1382, 234A, 2001. |
|
path |
|
| hn |
9709 |
Scarantino, C., Leveque, F. G., Scott, C., White, R., Rotman, M., Hodson, D., Meredith, R., Foote, R., Brachman, D. and Lee, N.: A Phase III Study of Concomitant Oral Pilocarpine to Reduce Hypo-Salivation and Mucositis Associated with Curative Radiation Therapy (RT) in Head and Neck (H & N) Cancer Patients. RTOG 9709. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #897, 225a, 2001. |
9709 |
cacon |
|
| hn |
9111 |
Forastiere, A., Berkey, B., Maor, M., Weber, R., Goepfert, H., Morrison, W., Glisson, B., Trotti, A., Ridge, J., Chao, C., Peters, G., Lee, D., Leaf, A. and Ensley, J.: Phase III Trial to Preserve the Larynx: Induction Chemotherapy and Radiotherapy Versus Concomitant Chemoradiotherapy Versus Radiotherapy Alone, Intergroup Trial R91-11. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #4, 2a, 2001. |
9111 |
medonc |
|
| hn |
|
Garden, A. S., Pajak, T., Vokes, E., Forastiere, A., Ridge, J., Jones, C., Horwitz, E., Glisson, B., Nabell, L., Cooper, J., Demas, W. and Gore, E.: Preliminary Results of RTOG 9703 – a Phase II Randomized Trial of Concurrent Radiation (RT) and Chemotherapy for Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #891, 223a, 2001. |
9703 |
chemo |
|
| hn |
9003 |
Konski, A., Scott, C., Ang, K. and Fu, K.: Does Dose Escalation of Radiotherapy (RT) Improve Quality-Adjusted Survival (QAS) in Unresectable Head and Neck Cancer (HNC) Patients (Pts)? Radiation Therapy Oncology Group (RTOG) Study 90-03. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #906, 227a, 2001. |
9003 |
ECON |
|
| hn |
|
Kumar, P., Robbins, K. T., Harris, J., McCulloch, T., Cmelak, A., Sofferman, R. and Levine, P.: Intra-Arterial (IA) Cisplatin (P) and Radiation Therapy (RT) is Feasible in a Multi-Institutional Setting for the Treatment of Stage IV-T4 Head/Neck (H/N) Squamous Cell Carcinoma (SCCa): Initial Results of Radiation Therapy Oncology Group (RTOG) Trial 9615. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #918, 230a, 2001. |
9615 |
chemo |
|
| hn |
|
Wheeler, R., Harris, J., Spencer, S., Machtay, M., Schultz, C., Spanos, W., Rotman, M. and Meredith, R.: RTOG 9610: Phase II Study of Reirradiation (RRT) with Concurrent Hydroxyurea (HU) and 5-Fluorouracil (FU) in Patients (Pts) with Recurrent Squamous Cell Cancer of the Head and Neck: Survival Results. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #887, 222a, 2001. |
9610 |
chemo |
|
| hn |
|
Al-Sarraf, M., LeBlanc, M., Giri, P. S., Fu, K., Cooper, J., Vuong, T., Forastiere, A., Adams, G., Sakr, W., Schuller, D. and Ensley, J.: Superiority of Five Year Survival with Chemo-Radiotherapy (CT-RT) vs Radiotherapy in Patients (Pts) with Locally Advanced Nasopharyngeal Cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: Final Report. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #905, 227a, 2001. |
8817 |
chemo |
|
| hn |
9003 |
Fu, K., Pajak, T., Trotti, A., Jones, C. U., Spencer, S. A., Phillips, T., Garden, A., Ridge, J., Cooper, J. and Ang, K.: A Radiation Therapy Oncology Group (RTOG) Phase III Randomized Study to Compare Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinomas: First Report of RTOG 90-03. Int J Rad Oncol Biol Phys, 48(1):7-16, 2000. |
9003 |
other (rt/fractionation) |
|
| hn |
|
Kumar, P., Harris, J., Robbins, K. T., Levine, P., McCulloch, T. and Sofferman, R.: The Feasibility of Using Intra-Arterial Cisplatin & Radiation Therapy for Stage IV-T4 Head/Neck Squamous Cell Carcinoma in a Multi-Institutional Setting: Preliminary Results of Radiation Therapy Oncology Group (RTOG) Trial 96-15. Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 152, Abs. #81, 2000. |
9615 |
chemo |
|
| hn |
|
Scott, C., Stern, J., Asbell, S., Brereton, D., Peer, J., Littman, P., Scarantino, C. and Bruner, D.: Quality of Life of Long-Term Survivors of Head and Neck or Prostate Cancer: Preliminary Results from a Survey of Survivors from Radiation Therapy Oncology Group (RTOG) Clinical Trials. Proceeding from Int Soc Qual of Life Research (ISOQOL), Vancouver, Canada, Quality of Life Research, pg. Abs. 2000. |
|
QOL |
|
| hn |
|
Spencer, S., Harris, J., Wheeler, R., Machtay, M., Shultz, C., Spanos, W., Rotman, M. and Meredith, R.: RTOG 96-10: Phase I Study of Reirradiation(RRT) with Concurrent Hydroxyurea(HU) and 5-Fluorouracil(FU) in Patients(PTS) with Squamous Cell Cancer of the Head and Neck(SCH&N). Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 177-178, Abs. #131, 2000. |
9610 |
chemo |
|
| hn |
|
Cooper, J., Berkey, B., Marcial, V., Fu, K. and Lee, D.: Validation of the RTOG Recursive Partitioning Analysis for Head and Neck Cancers. Int Conf on Head and Neck Cancer, San Francisco, CA, Final Program and Abstract Book: 5th Intl Conf on H & N Cancer, [Abstract #168], pg. 108, Abs. 2000. |
8527 |
stat |
|
| hn |
9003 |
Fisher, J., Scott, C., Fu, K., Trotti, A., Spencer, S., Garden, A., Phillips, T., Ridge, J., Byhardt, R., Yannuco, T. and Ang, K.: Randomized Study Comparing Quality of Life (QOL) Between Standard Fractionation Radiotherapy (RT) and Altered Fractionation Schemas in Patinets wtih Locally Advanced Squamous Cell Cancer of the Head and Neck: A Companion Study for Radiation Therapy Oncology Group (RTOG) 90-03. Int Conf on Head and Neck Cancer, San Francisco, CA, Final Program and Abstract Book: 5th Intl Conf on H & N Cancer, [Abstract #201], pg. 117, Abs. 2000. |
9003 |
QOL |
|
| hn |
9003 |
Hammond, E., Pajak, T., Fu, K., Trotti, A., Meredith, R., Jones, C., Byhardt, R., Horwitz, E. and Ang, K.: p105 as a Prognostic Indicator in Patients Irradiated for Locally Advanced Head and Neck Cancer: A Clinical/Laboratory Correlative Analysis of RTOG 9003. Int Conf on Head and Neck Cancer, San Francisco, CA, Final Program and Abstract Book: 5th Intl Conf on H & N Cancer, [Abstract #315], pg. 145, Abs. 2000. |
9003 |
surg |
|
| hn |
|
Hammond, E., Fitzgibbons, P., Compton, C., Grignon, D., Page, D., Fielding, L., Bostwick, D. and Pajak, T.: College of American Pathologists Conference XXXV: Solid Tumor Porgnostic Factors--Which, How and So What? Arch Pathol Lab Med, 124(July):958-965, 2000. |
|
path |
|
| hn |
|
Robbins, K. T., Harris, J., Kumar, P., Levine, P., McCulloch, T. and Sofferman, R.: Targeted Chemoradiation (RTOG 96-15) (RADPLAT) for T4 Carcinoma of fhe Upper Aerodigestive Tract: Interim Analysis of a Multi-Institutional Trial. Int Conf on Head and Neck Cancer, San Francisco, Final Program and Abstract Book: 5th Intl Conf on H & N Cancer, [Abstract #046], pg. 78, Abs. 2000. |
9615 |
chemo |
|
| hn |
|
Pignon, J., Bourhis, J., Domenge, C., Deisgne, L. and Group, M.-N.: Chemotherapy Added to Locoregional Treatment for Head and Neck Squamous Cell Carcinoma: Three Meta-Analysis of Updated Individual Data. The Lancet, 355(March 18):949-955, 2000. (RTOG/Meta Analysis) |
6801, 8503 |
stat |
|
| hn |
|
Aref, A., Berkey, B., Schwade, J., Ensley, J., Schuller, D., Haselow, R., Ervin, T. and Laramore, G.: The Influence of Beam Energy on the Outcome of Postoperative Radiotherapy in Head and Neck Cancer Patients: Secondary Analysis of RTOG 85-03. Int J Radiat Oncol Biol Phys, 47(2):389-394, 2000. |
8503 |
chemo/surg |
|
| hn |
|
Kim, E., Khuri, F., Lee, J., Winn, R., Cooper, J., Fu, K., Pajak, T., Lippman, S., Vokes, E., Broxson, A., Williams, B. and Hong, W.: Second Primary Tumor Incidence by Primary Index Tumor and Smoking Status on a Randomized Chemoprevention Study in Head and Neck Squamous Cell Cancer. Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [19], pg. 416a, Abs. #1642, 2000. (RTOG/SWOG/CALGB) |
9115 |
chemo |
|
| hn |
9003 |
Hammond, E., Berkey, B., Fu, K., Trotti, A., Meredith, R., Jones, C., Byhardt, R. and Horwitz, E.: Is p53 a Marker of Radioresistence in Head and Neck Cancer? A Laboratory Correlative Study from RTOG 90-03. Am Assoc for Cancer Res (AACR), San Francisco, CA, pg. Abs. 2000. |
9003 |
surg |
|
| hn |
|
Jacobs, J. R., Logemann, J., Pajak, T. F., Pauloski, B. R., Collins, S., Casiano, R. R. and Schuller, D. E.: Failure Of Cricopharyngeal Myotomy to Improve Dysphagia Following Head and Neck Cancer Surgery. Arch Otolary H&N Surg, 125(9):942-946, 1999. |
8503 |
|
|
| hn |
9003 |
Fu, K., Pajak, T., Trotti, A., Spencer, S., Jones, C., Phillips, T., Garden, A., Ridge, J., Cooper, J. and Ang, K.: A Radiation Therapy Oncology Group (RTOG) Phase III Randomized Study to Compare Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinomas: Preliminary Results of RTOG 9003. Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 145, Abs. #1, 1999. |
9003 |
rt/fractionation |
|
| hn |
9003 |
Owen, J., Grigsby, P., Caldwell, T., Konski, A., Johnson, D., Demas, W., Movsas, B., Jones, C. V. and Wasserman, T.: Can Costs Be Measured And Predicted By Modelling Within A Cooperative Clinical Trials Group? Economic Methodological Pilot Studies of Radiation Therapy Oncology Group (RTOG) Studies 90-03 and 91-04. Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 225, Abs. #150, 1999. |
9003,9104 |
ECON |
|
| hn |
|
Aref, A., Berkey, B., Schwade, J., Ensley, J., Schuller, D., Haselow, R., Ervin, T. and Laramore, G.: The Influence of Beam Energy on The Outcome of Postoperative Radiotherapy in Head And Neck Cancer Patients: Secondary Analysis of RTOG 85-03. Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 274, Abs. #1034, 1999. |
8503 |
rt/chemo/surg |
|
| hn |
|
Khuri, F., Lee, J., Winn, R., Benner, S., Lipppman, S., Fu, K., Cooper, J., Gacrama, P., Pajak, T., Goepfert, H. and Hong, W.: The Rate of SPT Development in a Randomized Chemoprevention Trial of HNSCC. 9th Inter'l Congress on Anticancer Treatment, Paris, France, pg. Abs. 1999. |
|
chemo |
|
| hn |
|
Al-Sarraf, M., LeBlanc, M., Giri, P., Fu, K., Cooper, J., Vuong, T., Forastiere, A., Adams, G., Sakr, W., Schuller, D. and Ensley, J.: Chemo-Radiotherapy (CT-RT) vs. Radiotherapy (RT) in Patients (Pts.) with Advanced Nasopharyngeal Cancer (NPC). Intergroup (0099) SWOG 8892, RTOG 8817, ECOG 2388 Phase III Study: Progress Report. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 385a, Abs. #1483, 1998. |
8817 |
chemo |
|
| hn |
|
Lee, W. R., Berkey, B., Marcial, V., Fu, K., Cooper, J., Vikram, B., Coia, L., Rotman, M. and Ortiz, H.: Anemia is Associated with Decreased Survival and Increased Locoregional Failure in Patients with Locally Advanced Head and Neck Carcinoma: A Secondary Analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys, 42(5):1069-1075, 1998. |
|
|
|
| hn |
|
Vokes, E. and Pajak, T.: Enhancing the Therapeutic Index of Concomitant Chemoradiotherapy and Head and Neck Cancer. Annals of Oncology, 9:471-473, 1998 (Editorial). |
|
sens/protect |
|
| hn |
|
Al-Sarraf, M., LeBlanc, M., Giri, P., Fu, K., Cooper, J., Vuong, T., Forastiere, A., Adams, G., Sakr, W., Schuller, D. and Ensley, J.: Chemoradiotherapy vs Radiotherapy in Patients with Locally Advanced Nasopharyngeal Cancer. Phase III Randomized Intergroup Study (0099) (SWOG 8892, RTOG 8817, ECOG 2388). J Clin Oncol, 16(4):1310-1317, 1998. |
|
|
|
| hn |
|
Lee, D., Pajak, T., Marcial, V., Fu, K., Rotman, M., Cooper, J., Ortiz, H., Beitler, J., Abrams, R., Curran, W., Coleman, C. and Wasserman, T.: Long Term Results of a Phase III Etanidazole Trial for Locally Advanced Head & Neck Carcinomas. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 384a, Abs. #1480, 1998. |
|
|
|
| hn |
|
Spitz, M. R., Lippman, S. M., Jiang, H., Lee, J., Khuri, F., Hsu, T., Trizna, Z., Schantz, S., Benner, S. and Hong, W.: Mutagen Sensitivity as a Predictor of Tumor Recurrence in Patients with Cancer of the Upper Aerodigestive Tract. J Natl Canc Instit, 90(3):243-245, 1998. |
|
cacon |
|
| hn |
|
Riese, N., Buswell, L., Noll, L., Pajak, T., Stetz, J., Lee, D. and Coleman, C. N.: Pharmacokinetic Monitoring and Dose Modification of Etanidazole in the RTOG 85-27 Phase III Head and Neck Trial. Int J Radiat Oncol Biol Phys, 39(4):855-858, 1997. |
|
QA/sens |
|
| hn |
|
Al-Sarraf, M., Martz, K., Herskovic , A., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Progress Report of Combined Chemoradiotherapy versus Radiotherapy Alone in Patients with Esophageal Cancer: An Intergroup Study (RTOG 85-01, SWOG 8598, NCCTG 884051). J Clin Oncol, 15(1):277-284, 1997. |
|
chemo |
|
| hn |
|
Cooper, J. S.: Current and Future Therapy of Nasopharyngeal Cancer. Int J Radiat Oncol Biol Phys, 37(5):973-974, 1997. |
|
other |
|
| hn |
|
Lee, W. R., Berkey, B., Marcial, V., Fu, K., Cooper, J., Vikram, B., Coia, L., Rotman, M. and Ortiz, H.: Anemia: Friend or Foe? Low Hemoglobin is Associated with Decreased Survival, Loco-Regional Control and Late Complications: A Secondary Analysis or RTOG 85-27. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 308, Abs. #2135, 1997. |
|
other |
|
| hn |
|
Al-Sarraf, M., Pajak, T., Byhardt, R., Beitler, J., Salter, M. and Cooper, J.: Postoperative Radiotherapy with Concurrent Cisplatin Appears to Improve Locoregional Control of Advanced, Resectable Head and Neck Cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys 37 (4):777-782, 1997. |
8824 |
chem/surg |
|
| hn |
|
Al-Sarraf, M., Pajak, T., Laramore, G., Jacobs, J., Ensley, J., Ahmad, S., Schuller, D., Haselow, R., Vokes, E., Markoe, A. and Byhardt, R.: Radiotherapy (RT) vs. Chemotherapy (CT) Followed by RT in Resected and Negative Margins Head and Neck Cancers (HNC). Intergroup Study 0034: Final Analysis. Proceedings of Proc of Am Soc Clin Oncol (ASCO), J Clin Oncol 16 :392a, 1997. |
8503 |
|
|
| hn |
|
Ensley, J., Laramore, G., Pajak, T., Alonso, M., Pietraskiewicz, H., Fu, K., Forastiere, A., Adams, G., Schuller, D. and Al-Sarraf, M.: DNA Content Parameters in Advanced, Resectable Squamouis Cell Carcinomas of the Head and Neck (SCCHN): Analysis of INT 0034, A RTOG (85-03) Administered Head and Neck Cancer Intergroup Trial. Proceedings of Proc of Am Soc Clin Oncol (ASCO), J Clin Oncol 16 :390a, 1997. |
8503 |
path |
|
| hn |
|
Jacobs, J.R., Logemann, J., Pajak, T.F., Roa-Pauloski, B., Collins, S., Casiano, R.R. and Schuller, D.E.: Failure of Cricopharyngeal Myotomy to Improve Dysphagia Following Head and Neck Cancer Surgery. Proceedings of 1997 Annual Triological Society, 1997. |
|
|
|
| hn |
|
Fu, K., Pajak, T., Marcial, V., Ortiz, H., Rotman, M., Asbell, S., Coia, L., Vora, N., Byhardt, R., Rubin, P., Sorgen, S., Cox, J. and Stetz, J.: Late Effects of Hyperfractionated Radiotherapy for Advanced Head and Neck Cancer: Long-Term Follow-up Results of RTOG 83-13. Int J Radiat Oncol Biol Phys, 32(3):577-588, 1995. |
8313 |
td/lateff |
|
| hn |
|
Cooper, J. S., Scott, C. B., Asbell, S. O., Rotman, M., Marcial, V., Fu, K. K., McKenna, W. G. and Emami, B.: Comparison of RPA-Derived Staging and AJCC Staging in Head and Neck Cancers Based on RTOG Data. Radiat Oncol Invest, 4):140-144, 1996. |
|
meth |
|
| hn |
|
Lee, D. J., Cosmatos, D., Marcial, V. A., Fu, K., Rotman, M., Cooper, J. S., Ortiz, H. G., Beitler, J. J., Abrams, R. A., Curran, W. J., Coleman, C. N. and Wasserman, T. H.: Results of an RTOG Phase III Trial (RTOG 85-27) Comparing Radiotherapy plus Etanidazole with Radiotherapy Alone for Locally Advanced Head and Neck Carcinomas. Int J Radiat Oncol Biol Phys, 32(3):567-576, 1995. |
8527 |
sens |
|
| hn |
|
Giri, P. S., LeBlanc, M., Al-Sarraf, M., Fu, K., Cooper, J., Vuong, T., Forastiere, A., Adams, G., Sakr, W., Schuller, D. and Ensley, J.: Improved Survival with Chemotherapy and Radiation Therapy versus Radiation Therapy Alone in Advanced Nasopharyngeal Cancer. Preliminary Results of an Intergroup Randomized Trial. INT 0099, SWOG 8892, RTOG 8817, ECOG 2388. Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA, Int J Radiat Oncol Biol Phys, 36 (1):162, [8], 1996. |
8817 |
chemo |
|
| hn |
|
Al-Sarraf, M., LeBlanc, M., Giri, P., Fu, K., Cooper, J., Vuong, T., Forastiere, A., Adams, G., Sakr, W., Schuller, D. and Ensley, J.: Superiority of Chemo-Radiotherapy (CT-RT) vs. Radiotherapy (RT) in Patients (Pts) with Locally Advanced Nasopharyngeal Cancer (NPC). Preliminary Results of Intergroup (0099) (SWOG 8892, RTOG 88-17, ECOG 2388) Randomized Study. Am Soc Clin Oncol (ASCO), Philadelphia, PA, Proc Am Soc Clin Oncol (ASCO), 15 (March 1996):313, [882], 1996. |
8817 |
|
|
| hn |
|
Wasserman, T., Pajak, T., Lee, D., Cosmatos, D. and Coleman, C. (. R.: RTOG Clinical Trials with Etanidazole. Proc of ESTRO and ECCO, November, 1993 1993. |
8527 |
chemmod/sens |
|
| hn |
|
Fu, K. K., Cox, J. D. and Pajak, T. F.: In Response to Bentzen and Thames: Regarding Dose-Response Relationships for Late Radiation Effects in the Head and Neck: Analysis of RTOG 83-13 Trial, Fu et al. IJROBP 32:577-588; 1995. Int J Radiat Oncol Biol Phys, 34(2):524-525, 1996. |
8313 |
lateff |
|
| hn |
|
Cooper, J. S., Farnan, N. C., Asbell, S. O., Rotman, M., Marcial, V., Fu, K. K., McKenna, W. G. and Emami, B.: A Comparison of RPA-Derived and AJC Staging in Head & Neck Cancers Based on RTOG Data. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):275, [2026], 1995. |
7619, 7913, 7915, 8313 |
stat/meth |
|
| hn |
|
Fu, K. K., Clery, M., Ang, K. K., Byhardt, R. W., Maor, M. M. and Beitler, J. J.: Randomized Phase I/II Trial of Two Variants of Accelerated Fractionated Radiotherapy Regimens for Advanced Head and Neck Cancer: Results of RTOG 88-09. Int J Radiat Oncol Biol Phys, 32(3):589-598, 1995. |
8809 |
td |
|
| hn |
|
Cosmatos, D. and Pajak, T. F.: Statistical Response to Dr. J. Martin Brown's editorial, "Hypoxic Cell Radiosensitizers: The End of an Era?" (IJROBP 32:883-885; 1995). Int J Radiat Oncol Biol Phys, 32(4):1265, 1995. |
8527 |
stat/sens |
|
| hn |
|
Cooper, J. S., Fu, K., Marks, J. and Silverman, S.: Late Effects of Radiation Therapy in the Head and Neck Region. Int J Radiat Oncol Biol Phys, 31(5):1141-1164, 1995. |
|
lateff |
|
| hn |
|
Fu, K. K. and Cox, J. D.: Late Effects of Hyperfractionated Radiotherapy for Head and Neck Cancer. Int J Radiat Oncol Biol Phys, 32(4):1266, 1995. |
8313 |
lateff/td |
|
| hn |
|
Cooper, J., Farnan, N., Asbell, S., Rotman, M., Marcial, V., Fu, K., McKenna, W. and Emami, B.: Recursive Partitioning Analysis of 2,105 Patients Treated in RTOG Studies of Head and Neck Cancer. Cancer, 77:1905-1911, 1996. |
7619, 7913, 7915, 8313 |
stat/meth |
|
| hn |
8501 |
Al-Sarraf, M., Martz, K., Herskovic , A., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B.: Progress Report of Combined Chemoradiotherapy versus Radiotherapy Alone in Patients with Esophageal Cancer: An Intergroup Study (RTOG 85-01, SWOG 8598, NCCTG 884051). J Clin Oncol, 15(1):277-284, 1997. |
8501 |
chemo |
|
| hn |
|
Lee, D.-J., Fu, K. K., Cooper, J. S. and Wasserman, T. H.: "End of an Era or Not? That is the Question." In Response to J.M. Brown, IJROBP 32:883-885; 1995. Int J Radiat Oncol Biol Phys, 32(4):1263, 1995. |
8527 |
sens |
|
| hn |
|
Coleman, C. N.: "Reports of My Death [may be] Greatly Exaggerated" (adapted from Mark Twain) - In Response to Dr. J.M. Brown, IJROBP 32:883-885; 1995. Int J Radiat Oncol Biol Phys, 32(4):1264, 1995. |
8527 |
sens |
|
| hn |
|
Fu, K. K., Cooper, J. S., Marcial, V. A., Laramore, G. E., Pajak, T. F., Jactobs, J., Al-Sarraf, M., Forastiere, A. A. and Cox, J. D.: Evolution of the Radiation Therapy Oncology Group Clinical Trials for Head and Neck Cancer. Int J Radiat Oncol Biol Phys, 35(3):425-438, 1996. |
|
chemo/surg |
|
| hn |
|
Al-Sarraf, M., Pajak, T., Byardt, R., Beitler, J., Salter, M. and Cooper, J.: Concurrent Cisplatin and Post-Operative Radiotherapy (RT) in Patients (pts) with Stage IV and/or Positive Margins Head and Neck Cancers. RTOG Study 88-24. Sixth International Congress on Anti-Cancer Treatment, Paris, France, Proc Am Assoc Canc Res, 37 (March 1996):171, [1175], 1996. |
8824 |
chemo/surg |
|
| hn |
|
Benner, S., Pajak, T., Lippman, S., Schantz, S., Gallagher, M., Shenouda, G., Stetz, J. and Hong, W.: Toxicity of Isotretinoin in a Chemoprevention Trial to Prevent Second Primary Tumors Following Head and Neck Cancer. J Natl Can Inst, 23(86 (Dec 7)):1799-1801, 1994. |
9115 |
cacon/BRM |
|
| hn |
|
Cooper, J. S., Farnan, N., Asbell, S., Rotman, M., Marcial, V., Fu, K., McKenna, W. and Emami, B.: Recursive Partitioning Analysis of 2,105 Patients Treated in RTOG Studies of Head and Neck Cancer. ARS (95), Paris, France, Proceedings of the American Radium Society 78th Annual Meeting, April 29-May 3 (meeting dates) 18-19, [15], 1995. |
7619, 7913, 7915, 8313 |
stat/meth |
|
| hn |
|
Riese, N., Buswell, L., Noll, L., Pajak, T., Stetz, J., Lee, D. and Coleman, C. N.: Pharmacokinetic Monitoring and Dose Modification of Etanidazole in the RTOG 85-27 Phase III Head and Neck Trial. Oxford Chemomodifer Meeting, Christ Church, Oxford, UK, 1995. |
8527, 8813 |
QA/sens |
|
| hn |
|
Weymuller, E. A., Ahmad, K., Casiano, R. R., Laramore, G., Schuller, D., Al-Sarraf, M., Scott, C. B. and Jacobs, J. R.: Surgical Reporting Instrument Designed to Improve Outcome Data in Head and Neck Cancer Trials. Ann Otol Rhinol Laryngol, 103:499-509, 1994. |
8503 |
surg/QA/meth |
|
| hn |
|
Schuller, D. E., Scott, C., Wilson, K. M., Freer, R., Al-Sarraf, M., Jacobs, J., Ahmad, K., Casiano, R. and Laramore, G.: The Effect of Perioperative Blood Transfusion on Survival in Head and Neck Cancer. Arch Otolaryngol Head Neck Surg, 120(July):711-716, 1994. |
8503 |
surg |
|
| hn |
|
Al-Sarraf, M., Scott, C., Laramore, G., Haselow, R., Ervine, T., Wheeler, R. and Jacobs, J.: Phase III Study Comparing Sequential, Chemotherapy (ct) and Radiotherapy (rt) and RT for Resected and Negative (-) Margins Squamous Cell Carcinoma (ca) of the Head & Neck: Intergroup Study 0034. Proc Am Soc Clin Oncol (ASCO), 11 242, [778], 1992. |
8503 |
chemo/surg |
|
| hn |
|
Lee, D., Phillips, T., Coleman, C., Cosmatos, D., Davis, L., Wasserman, T., Marcial, V. and Rubin, P.: Logistics in Designing Clinical Trials for Etanidazole (SR 2508): An RTOG Experience. Int J Radiat Oncol Biol Phys, 22(3):569-571, 1992. |
8527 |
sens |
|
| hn |
|
Lee, D., Phillips, T., Coleman, C., Cosmatos, D., Davis, L., Wasserman, T., V, M. and Rubin, P.: Logistics in Designing Clinical Trials for SR 2508 (etanidazole): An RTOG Experience. International Conference on Chemical Modifiers of Cancer Treatment, Clearwater, FL, 166, [C16], 1991. |
8527 |
sens |
|
| hn |
|
Leibel, S., Scott, C., Mohiuddin, M., Marcial, V., Coia, L., Davis, L. and Fuks, Z.: The Effect of Local-Regional Control On Distant Metastatic Dissemination in Carcinoma of the Head and Neck: Results of an Analysis From the RTOG Head and Neck Database. Int J Radiat Oncol Biol Phys, 21:549-556, 1991. |
|
other |
|
| hn |
|
Marcial, V. A., Pajak, T. F., Rotman, M., Brady, L. W. and Amato, D.: "Compensated" Split-Course versus Continuous Radiation Therapy of Carcinoma of the Tonsillar Fossa. Final Results of a Prospective Randomized Clinical Trial of the Radiation Therapy Oncology Group. Am J Clin Oncol (CCT), 16(5):389-396, 1993. |
7101 |
td |
|
| hn |
|
Laramore, G., Scott, C., Al-Sarraf, Haselow, R., Ervin, T., Wheeler, R. and Jacobs, J.: Adjuvant Chemotherapy for Resectable Squamous Cell Carcinomas of the Head and Neck: Report on Intergroup Study 0034. Proc Am Soc Thera Radiol Oncol (ASTRO), Int J Radiat Oncol Biol Phys, 21 (1):190, [140], 1991. |
8503 |
chemo/surg |
|
| hn |
|
Laramore, G., Scott, C., Schuller, D., Haselow, R., Ervin, T., Wheeler, R., Al-Sarraf, M., Gahbauer, R., Jacobs, J., Schwade, J. and Campbell, B.: Is a Surgical Resection Leaving Positive Margins of Benefit to the Patient with Locally-Advanced Squamous Cell Carcinoma of the Head and Neck? Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):173, [83], 1992. |
8503 |
chemo/surg |
|
| hn |
|
Laramore, G., Scott, C., Al-Sarraf, M., Haselow, R., Ervin, T., Wheeler, R., Jacobs, J., Schuller, D., Gahbauer, R., Schwade, J. and Campbell, B.: Adjuvant Chemotherapy for Resectable Squamous Cell Carcinomas of the Head and Neck: Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys, 23:706-713, 1992. |
8503 |
chemo/surg |
|
| hn |
|
Laramore, G., Scott, C., Schuller, D., Haselow, R., Ervin, T., Wheeler, R., Al-Sarraf, M., Gahbauer, R., Jacobs, J., Schwade, J. and Campbell, B.: Is a Surgical Resection Leaving Positive Margins of Benefit to the Patient with Locally-Advanced Squamous Cell Carcinoma of the Head and Neck? Int J Radiat Oncol Biol Phys, 27(5):1011-1016, 1993. |
8503 |
surg |
|
| hn |
|
Wasserman, T., Lee, D., Cosmatos, D., Coleman, N., Phillips, T., Davis, L., Marcial, V. and Stetz, J.: Clinical Trials with Etanidazole (SR-2508) by the Radiation Therapy Oncology Group (RTOG): A Brief Report. Radiother Oncol, 20:129-135, 1991. |
8527 |
sens |
|
| hn |
|
Tupchong, L., Scott, C., Blitzer, P., Marcial, V., Lowry, L., Jacobs, J., Stetz, J., Davis, L., Snow, J., Chandler, R., Kramer, S. and Pajak, T.: Randomized Study of Preoperative vs. Postoperative Radiation Therapy in Advanced Head and Neck Carcinoma. Long-term Follow-up of RTOG Study 73-03. Int J Radiat Oncol Biol Phys, 20:21-28, 1991. |
7303 |
surg |
|
| hn |
|
Fu, K. K., Hammond, E., Pajak, T. F., Clery, M., Doggett, R., Byhardt, R. W. and McDonald, S.: Flow Cytometric Quantification of Proliferation-Associated Nuclear Antigen p105 and DNA Content in Advanced Head & Neck Cancers: Results of RTOG 91-08. Int J Radiat Oncol Biol Phys, 29(4):661-71, 1994. |
9108 |
path |
|
| hn |
|
Pajak, T., Laramore, G., Marcial, V., Fazekas, J., Cooper, J., Rubin, P., Curran, W. and Davis, L.: Elapsed Treatment Days - A Critical Item for Radiotherapy Quality Control Review in Head and Neck Trials: RTOG Report. Int J Radiat Oncol Biol Phys, 20:13-20, 1991. |
7913, 7915 |
QA/td |
|
| hn |
|
Pajak, T. and Jacobs, J.: Unappreciated Impact of Potentially "Curative" Surgery (pcs) in Multi-Modality Head and Neck (h+n) Trials Upon Sample Size Requirements. International Conference on Head and Neck Cancer, San Francisco, 121, [283], 1992. |
7303, 8503 |
surg |
|
| hn |
|
Schuller, D., Scott, C., Wilson, K., Freer, R., Al-Sarraf, M., Jacobs, J., Ahmad, K., Casiano, R. and Laramore, G.: The Effect of Peri-Operative Blood Transfusion on Survival in Head and Neck Cancer. International Conference on Head and Neck Cancer, San Francisco, 103, [211], 1992. |
8503 |
chemo/surg |
|
| hn |
|
Jacobs, J. R., Casiano, R. R., Schuller, D. E., Pajak, T. F., Laramore, G. E. and Al-Sarraf, M.: Chemotherapy as Predictor of Compliance. J Surg Oncol, 55:143-148, 1994. |
8503 |
chemo |
|
| hn |
|
Cooper, J. S.: Postoperative Irradiation in Head and Neck Cancer. Int J Radiat Oncol Biol Phys, 26(1):181-182, 1993. |
7303, 8503 |
surg |
|
| hn |
|
Cooper, J., Scott, C., Marcial, V., Griffin, T., Fazekas, J., Laramore, G. and Hoffman, A.: The Relationship of Nasopharyngeal Carcinomas and Second Independent Malignancies Based on the RTOG Experience. Cancer, 67:1673-1676, 1991. |
|
other |
|
| hn |
|
Cox, J., Pajak, T., Marcial, V., Coia, L., Mohiuddin, M., Fu, K., Selim, H., Rubin, P. and Ortiz, H.: Interruptions Adversely Affect Local Control and Survival with Hyperfractionated Radiation Therapy of Carcinomas of the Respiratory/Digestive Tracts: New Evidence for Accelerated Proliferation from RTOG Protocol 83-13. Proc American Radium Society, Montreal, 1-2, [3], 1991. |
8313 |
td |
|
| hn |
|
Cox, J., Pajak, T., Marcial, V., Coia, L., Mohiuddin, M., Fu, K., Selim, H., Byhardt, R., Rubin, P., Ortiz, H. and Martin, L.: Interruptions Adversely Affect Local Control and Survival with Hyperfractionated Radiation Therapy of Carcinomas of the Upper Respiratory and Digestive Tracts. New Evidence for Accelerated Proliferation from Radiation Therapy Oncology Group Protocol 83-13. Cancer, 69(11):2744-2748, 1992. |
8313 |
td |
|
| hn |
|
Al-Sarraf, M., Cosmatos, D., Ahmad, K., Fields, JN, Byhardt, R., Davis, L., Cooper, J. and Curran, W.: Post-operative (post-op) Concomitant Cisplatin (cacp) and Radiotherapy (rt) in Patients (pts) with Stage IV and/or Positive Margins Head and Neck Cancer. A RTOG Study. International Conference on Head and Neck Cancer, San Francisco, 183, [534], 1992. |
8824 |
chemo/surg |
|
| hn |
|
Al-Sarraf, M., Cosmatos, D., Ahmad, K., Fields, J., Byhardt, R., Davis, L., Cooper, C. and Curran, W.: Significant Loco-Regional Control (lrc) and Survival in Patients (pts) with Stage IV and/or Positive (+) Margins Head and Neck Cancer (hnca) Treated with Post-operative (post-op) Concurrant Cisplatin (cacp) and rt. A Radiation Therapy Oncology Group (RTOG) Study. Proc Am Soc Clin Oncol (ASCO), 11 242, [777], 1992. |
8824 |
chemo/surg |
|
| hn |
|
Jacobs, J., Ahmad, K., Casiano, R., Schuller, D., Scott, C., Laramore, G. and Al-Sarraf, M.: Implications of Positive Surgical Margins. Laryngoscope, 103:64-68, 1993. |
8503 |
surg |
|
|
